CONSENT CALENDAR
All matters listed on the consent calendar are considered to be routine and will be
acted upon by one motion. There will be no separate discussion of these items. If
a member of the public would like a consent calendar item pulled and discussed
separately, please refer to the notice at the beginning of this agenda.
Approve Planning Commission Meeting Minutes of August 12, 2024
1.
Recommendation:
Approve Planning Commission Meeting Minutes of August 12,
2024 as submitted.
PUBLIC HEARINGS/GENERAL BUSINESS
If you wish to speak to a public hearing/general business item, please refer to
notice at the beginning of this agenda. Each speaker is limited to a maximum of
three minutes. For land-use items, applicants are limited to a maximum of 10
minutes for opening comments and 5 minutes for closing comments.
Proposed Project:
SPECIAL DEVELOPMENT PERMIT: Demolish two existing
2.
used auto sales buildings and construct a mixed-use project:
1) A six-story senior housing building including approximately
12,232 square feet of commercial floor area, 113 independent
living units, and 36 assisted living accommodations; and,
2) A three-story convalescent hospital building with 72,000
square feet of floor area and a 52-bed capacity.
Location: 1027-1035 West El Camino Real (APN: 161-41-009)
File #: PLNG-2023-0234
Zoning: ECR-MU42 (El Camino Real Mixed Use)
Applicant / Owner: PMB LLC (applicant) / Nicholas Gera (owner)
Environmental Review: No additional review required as per CEQA
Guidelines 15183 - environmental impacts of the project are addressed
in the El Camino Real Specific Plan (ECRSP) Environmental Impact
Report (EIR)
Project Planner: Jeffrey Cucinotta, (408) 730-7424,
Recommendation:
Alternative 1. Make the required findings to approve the CEQA
determination that the project is consistent with the ECRSP
EIR and no additional environmental review is required
pursuant to CEQA Guidelines Section 15183 and approve the
Special Development Permit based on the Recommended
Findings in Attachment 3 and Recommended Conditions of
Approval in Attachment 4.